Yum China delivers $3.1B revenue as sales jump 13%
Yum China Holdings (NYSE:YUMC) reported second-quarter 2026 revenue of $3.14 billion, up 13% year over year, supported by store expansion, delivery growth and higher system sales.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Yum China Holdings (NYSE:YUMC) reported second-quarter 2026 revenue of $3.14 billion, up 13% year over year, supported by store expansion, delivery growth and higher system sales.
Group 1 Automotive (NYSE:GPI) reported second-quarter 2026 revenue of $5.4 billion, down 5.6% year over year, as lower vehicle volumes and finance-related revenue reduced results.
Lockheed Martin (NYSE:LMT) received a seven-year undefinitized contract action modification from the U.S. government worth up to $53.9 billion to produce PAC-3 Missile Segment Enhancement (MSE) interceptors.
Mesoblast (NASDAQ:MESO) reported preliminary Ryoncil® net revenue of $36 million for the June 2026 quarter, bringing first-year post-FDA approval revenue to $115 million.
ING Groep (NYSE:ING) reported a second-quarter 2026 net result of €1.9 billion, up 23% year over year, supported by higher interest and fee income.
ArcelorMittal (NYSE:MT) reported second-quarter 2026 sales of $16.8 billion, up 8.4% quarter over quarter, with EBITDA of $2.1 billion as margins improved.
Pharming (NASDAQ:PHAR) reported preliminary second-quarter 2026 revenue of $90.2 million, down 3% year over year, as lower RUCONEST sales offset growth from Joenja.
Anheuser-Busch InBev (NYSE:BUD) reported second-quarter 2026 reported revenue of $16.7 billion, up 11%, with underlying revenue growth of 5.6% driven by higher revenue per hectoliter and volume growth.
The Magnum Ice Cream Company (NYSE:MICC) reported first-half 2026 revenue of €4.7 billion, up from €4.5 billion a year earlier, driven by 4.7% organic sales growth across all regions.
Stellantis (NYSE:STLA) reported second-quarter 2026 net revenues of €43.5 billion, up 13% year over year, as growth in North America and South America supported higher sales.
ASE Technology Holding (NYSE:ASX) reported second-quarter 2026 revenue of NT$191.1 billion, up 26.7% year over year, as higher semiconductor packaging and testing demand lifted results.
Takeda Pharmaceutical (NYSE:TAK) reported first-quarter revenue of ¥1.22 trillion, up 10.2%, as core brands offset weaker VYVANSE sales.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade